微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.94% | -74.54% | 55.2% | 87/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.25% | -75.63% | 52.44% | 82/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.82% | -73.2% | -88.67% | 79/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.24% | -56.59% | -4.99% | 54/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 7.62% | -42.71% | 48.54% | 43/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.13% | -37.44% | 67.65% | 45/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.06% | -35.98% | -81.65% | 41/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 16.68% | -14.81% | 25.41% | 37/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 13.3% | -8.59% | 62.2% | 37/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 8.2% | 1.11% | 71.55% | 41/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 4.78% | 58.28% | -75.59% | 32/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 19.58% | 65.09% | 34.57% | 41/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 14.55% | 65.72% | 79.41% | 39/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 8.11% | 93.56% | 168.54% | 51/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.02% | 104.05% | -74.54% | 53/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 11.86% | 325.09% | 35.08% | 80/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 8.78% | 341.21% | 109.55% | 56/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.19% | 791.49% | 183.11% | 77/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.48% | 179.25% | -46.95% | 51/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 2.79% | 257.69% | 40.2% | 101/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 1.99% | -8.72% | 323.4% | 58/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 0.47% | -48.91% | -11.32% | 71/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.53% | -26.39% | -32.05% | 48/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 0.78% | -71.74% | -64.22% | 98/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 2.18% | -41.24% | 136.96% | 50/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.92% | -61.98% | 27.78% | 50/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 0.72% | -59.09% | -73.91% | 43/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 2.76% | -58.74% | -25.61% | 87/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.71% | -42.03% | 53.31% | 40/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.42% | -42.65% | 37.5% | 48/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.76% | -40.94% | -73.69% | 29/129 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 6.69% | -49.51% | 4.53% | 62/129 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.4% | -32.2% | 51.66% | 22/129 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.22% | -41.55% | 41.61% | 29/129 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 2.98% | -21.58% | -77.51% | 11/129 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 13.25% | 5.16% | 40.36% | 30/129 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 9.44% | 16.69% | 30.75% | 12/129 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 7.22% | 23.21% | 90% | 19/129 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 3.8% | 37.18% | -69.84% | 12/129 | 3.2% | 中源协和 | 14.44% | 行业排名> |